Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2006 by Lampiris, Harry W., M.D..
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Abbott
Information provided by:
Lampiris, Harry W., M.D.
ClinicalTrials.gov Identifier:
NCT00247143
First received: October 28, 2005
Last updated: September 18, 2006
Last verified: September 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given